Literature DB >> 3192638

The retention of [99mTc]-d,l-HM-PAO in the human brain after intracarotid bolus injection: a kinetic analysis.

N A Lassen1, A R Andersen, L Friberg, O B Paulson.   

Abstract

[99mTc]-d,l-HM-PAO (HM-PAO) was injected rapidly into the internal carotid artery and its retention in the brain was recorded by external scintillation cameras in eight human subjects. A model is described based on three compartments: the lipophilic tracer in the blood pool of the brain, the lipophilic tracer inside the brain, and the hydrophilic form retained in the brain. The retention curve initially drops abruptly, corresponding to the nonextracted fraction of the injectate leaving the brain; it then falls exponentially towards the asymptotic level of the fractional steady-state retention R. Cerebral blood flow (F) was measured using the xenon-133 intracarotid injection method. The first-pass extraction E of HM-PAO was calculated from F using an empiric regression equation. The residue curves for the whole brain after intracarotid HM-PAO injection were analyzed to yield a retention fraction (R') and the brain clearance backflux constant of lipophilic HM-PAO (k). From the kinetic model and the measured values of R', k, and F, the following parameter values could be calculated: the average retained fraction of all tracer supplied to the brain, R = 0.38 +/- 0.05 (mean +/- SD), the conversion rate constant (lipophilic to hydrophilic tracer) in the brain k3 = 0.80 +/- 0.12 min-1, the efflux rate constant (brain to blood) k2 = 0.69 +/- 0.11 min-1, the conversion/clearance ratio alpha = k3/k2 = 1.18 +/- 0.25, the influx (blood clearance) constant K1 = 0.45 +/- 0.11 ml/g/min, and the brain/blood partition ratio lambda = K1/k2 = 0.67 +/- 0.23 ml/g. Using the kinetic model and assuming constancy of alpha, an algorithm was developed that corrects for the blood flow dependent backflux of HM-PAO and results in a more linear relation between regional cerebral blood flow (rCBF) and HM-PAO distribution.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3192638     DOI: 10.1038/jcbfm.1988.28

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  47 in total

1.  Motor stimulation response by technetium-99m hexamethylpropylene amine oxime split-dose method and single photon emission tomography.

Authors:  P Pantano; V Di Piero; M Ricci; C Fieschi; L Bozzao; G L Lenzi
Journal:  Eur J Nucl Med       Date:  1992

Review 2.  Cerebral blood flow changes in migraine: methods, observations and hypotheses.

Authors:  L Friberg
Journal:  J Neurol       Date:  1991       Impact factor: 4.849

3.  Memory-provoked rCBF-SPECT as a diagnostic tool in Alzheimer's disease?

Authors:  Torbjörn Sundström; Eva Elgh; Anne Larsson; Birgitta Näsman; Lars Nyberg; Katrine A Riklund
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-09-09       Impact factor: 9.236

4.  A quantitative approach to technetium-99m hexamethylpropylene amine oxime.

Authors:  H Matsuda; S Tsuji; N Shuke; H Sumiya; N Tonami; K Hisada
Journal:  Eur J Nucl Med       Date:  1992

5.  Required time delay from 99mTc-HMPAO injection to SPECT data acquisition: healthy subjects and patients with rCBF pattern.

Authors:  Gerda Thomsen; Robin de Nijs; Esben Hogh-Rasmussen; Vibe Frokjaer; Claus Svarer; Gitte M Knudsen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-06-10       Impact factor: 9.236

6.  Case report: regional cerebral hypoperfusion induced by ventricular tachycardia - short-term hippocampal hypoperfusion and its potential relationship to selective neuronal damage.

Authors:  A Hagendorff; E Klemm; M Bangard; C Dettmers; C Wolpert; B Schumacher; H J Biersack; F Grünwald; B Lüderitz; D Pfeiffer
Journal:  J Interv Card Electrophysiol       Date:  2001-12       Impact factor: 1.900

7.  Cerebellar vascular response to acetazolamide in crossed cerebellar diaschisis: a comparison of 99mTc-HMPAO single-photon emission tomography with 15O-H2O positron emission tomography.

Authors:  Y Kuwabara; Y Ichiya; M Sasaki; Y Akashi; T Yoshida; T Fukumura; K Masuda
Journal:  Eur J Nucl Med       Date:  1996-06

8.  Brain single-photon emission CT studies using 99mTc-HMPAO and 99mTc-ECD early after recanalization by local intraarterial thrombolysis in patients with acute embolic middle cerebral artery occlusion.

Authors:  K Ogasawara; A Ogawa; M Ezura; H Konno; M Suzuki; T Yoshimoto
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

9.  Quantification of functional deficit in Alzheimer's disease using a computer-assisted mapping program for 99mTc-HMPAO SPECT.

Authors:  H Karbe; A Kertesz; J Davis; B J Kemp; F S Prato; R L Nicholson
Journal:  Neuroradiology       Date:  1994       Impact factor: 2.804

10.  Quantification of technetium-99m hexamethylpropylene amine oxime brain uptake in routine clinical practice using calibrated point sources as an external standard: phantom and human studies.

Authors:  A Dobbeleir; R Dierckx
Journal:  Eur J Nucl Med       Date:  1993-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.